Rolf Kiessling

Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation

R. Kiessling, K. Mimura, K. Kono, 2013, Cell Death and Disease.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, David M. Schauder, 2016, Journal for ImmunoTherapy of Cancer.

Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells.

A. Sette, E. Appella, R. Kiessling, 1997, Cancer research.

Tumor‐dependent down‐regulation of the ζ‐chain in T‐cells is detectable in early breast cancer and correlates with immune cell function

R. Kiessling, Y. Mao, J. Boniface, 2012, International journal of cancer.

Diverse effect of cytokine treatment of tumor cells on specific versus non-specific cytotoxicity

E. Halapi, R. Kiessling, H. Mellstedt, 1992, Medical oncology and tumor pharmacotherapy.

Tumor‐induced changes in the phenotype of blood‐derived and tumor‐associated T cells of early stage breast cancer patients

J. Boniface, I. Poschke, Yumeng Mao, 2012, International journal of cancer.